analyst Simos Simeonidis

Related by string. * analysts . ANALYST . ANALYSTS . Analysts . Analyst : WHAT 'S EXPECTED Analysts . Zacks Analyst Blog Highlights . Analysts polled . analysts polled . Interviews Analyst . Investors Observer Analysts Favorites . Analysts Begin Coverage / SIMO : Xi'an Simo . Pepe Simo . Louis Simo Adrien . Simo Valakari . Louis Simo . Simo Kirssi . Simo Holdings / : Simos Simeonidis . Simeonidis * *

Related by context. Frequent words. (Click for all words.) 57 Afrezza 54 Avanir 53 ONXX 53 AMLN 53 HGSI 52 Funtleyder 52 Exanta 52 Genzyme GENZ 51 Momenta Pharmaceuticals 51 Novartis NVS 51 Eli Lilly NYSE LLY 51 Antegren 51 cladribine 51 VRTX 50 MYGN 50 asenapine 50 PDLI 50 Lazard Capital 50 OSIP 50 Biogen Idec Inc 50 Synta Pharmaceuticals 49 Biogen 49 Amgen AMGN 49 daclizumab 49 midstage study 49 Biogen Idec BIIB 49 Market Perform rating 49 ALXN 49 Corcept 49 Allos Therapeutics 48 Cordaptive 48 Incyte 48 Speculative Buy 48 Roche Holding AG ROG.VX 48 GENZ 48 Outperform rating 48 Amgen NASDAQ AMGN 48 denosumab 48 Horizant 48 Ariad 48 Novartis NYSE NVS 48 Xiaflex 47 AstraZeneca AZN 47 AMGN 47 ViroPharma 47 BIIB 47 Vivus 47 Protalix 47 NMT Medical 47 Idenix Pharmaceuticals Inc. 47 Oscient 47 Regeneron Pharmaceuticals Inc. 47 Savient Pharmaceuticals 47 Cubicin 47 Neurocrine Biosciences 47 Encysive 47 Eli Lilly LLY 47 Immunomedics 47 Vertex Pharmaceuticals 47 Eyetech 47 Overweight rating 47 Theravance 47 Neutral rating 47 Antigenics 47 NeuroSearch 46 Schering Plough SGP 46 BMY 46 BioMarin 46 3SBio 46 Underperform rating 46 Aspreva 46 Revlimid 46 CE Unterberg Towbin 46 Cypress Bioscience 46 Celgene 46 Pain Therapeutics 46 Onyx Pharmaceuticals 46 tanezumab 46 Glenmark Pharma 46 MannKind 46 CoTherix 46 prasugrel 46 Oxford BioMedica 46 AMAG Pharmaceuticals Inc. 46 Xoma 46 Opexa 45 Stada 45 Tranzyme 45 Kuvan 45 Human Genome Sciences 45 Landesbank Rheinland Pfalz 45 Sanofi Aventis NYSE SNY 45 PRGO 45 Dendreon 45 Leerink Swann analyst 45 Jerini 45 Santhera 45 Par Pharmaceutical Companies 45 Pargluva 45 Molecular Insight 45 Idenix

Back to home page